In particular, to assess the translational potential, tumor biopsies from patients subjected to immunotherapy were used to establish syngeneic colon cancer models to target granzyme B expression using a peptide-based probe ([68Ga]Ga-NOTA-GZP). The gene discussed is GZMB; the disease is neoplasm.